Overview and Scope
The rat model refers to a process that uses rat functional genes, cells, tissues, and organs. These mouse models are employed to simulate both pathological and healthy conditions of the human immune system. The use of humanized rat models is crucial for preclinical research since they may be used to simulate human disease states, evaluate the effectiveness of compounds, and examine how they affect human proteins.
Sizing and Forecast
The rat model market size has grown strongly in recent years. It will grow from $1.56 billion in 2023 to $1.69 billion in 2024 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising demand for preclinical research, increasing government funding, research demand, drug development initiatives, rising chronic disease.
The rat model market size is expected to see strong growth in the next few years. It will grow to $2.34 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to expanding applications in personalized medicine, growing demand for animal models in drug discovery, increasing focus on disease prevention, expansion of biopharmaceutical industry, innovation in imaging techniques, government and private funding. Major trends in the forecast period include global collaborations in research, technological advancements in imaging, integration of omics technologies, advancements in genome editing techniques, growing importance of rat models in disease research, rise of personalized medicine and customized rat models.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/rat-model-global-market-report
Segmentation & Regional Insights
The rat model market covered in this report is segmented –
1) By Type: Knockout, Outbred, Inbred, Hybrid, Immunodeficient, Conditioned
2) By Service: Cryopreservation, Breeding, Re-derivation, Genetic Testing, Quarantine Depending, Other Services
3) By Technology: Nuclear Transferase, Microinjection, Embryonic Stem Cell, Other Technologies
4) By Application: Oncology, Neurology, Immunology, Toxicology, Other Applications
North America was the largest region in the rat model market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global rat model market report during the forecast period. The regions covered in the rat model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=10100&type=smp
Major Driver Impacting Market Growth
The rising incidence of chronic diseases is expected to boost the growth of the rat model market going forward. Chronic diseases refer to conditions that last for a year or longer, hinder everyday activities, demand continuous medical care, or both. Rat models have been instrumental in studying the pathogenesis, immune responses, and treatment of chronic infections, providing valuable insights that can inform the development of new therapies and interventions. For instance, according to a report published by the National Institutes of Health (NIH), a US-based biomedical research agency, in 2023, in the United States, the number of people aged 50 and older with at least one chronic illness is predicted to rise by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050. Additionally, the number of people with multimorbidity would rise by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Therefore, the rising incidence of chronic diseases is driving the growth of the rat model market.
Key Industry Players
Major companies operating in the rat model market report are Genoway S.A., Biomere, Transposagen Biopharmaceuticals Inc., Horizon Discovery Group PLC, Transviragen Inc., Charles River Laboratories International Inc., Taconic Biosciences Inc., Envigo Ltd., Laboratory Corporation of America Holdings, Janvier Labs, Harlan Laboratories Inc., Sage Path Labs, Applied StemCell Inc., Regenera Pharma Ltd., Cyagen Biosciences Inc., Ozgene Pty Ltd., Yecuris Corporation, Hera BioLabs Inc., Beijing Biocytogen Co. Ltd., Ingenious Targeting Laboratory, InVivos Pte Ltd., Kymab Limited, Mirimus Inc., Pharmaron Beijing Co. Ltd., PolyGene AG, Shanghai Model Organisms Center Inc., Sino Biological Inc., Synthego Corporation, Transgenic Inc., ViGene Biosciences Inc., Viva Biotech Holdings, WuXi AppTec Co. Ltd.
The rat model market report table of contents includes:
1. Executive Summary
2. Rat Model Market Characteristics
3. Rat Model Market Trends And Strategies
4. Rat Model Market – Macro Economic Scenario
5. Global Rat Model Market Size and Growth
.
.
.
31. Global Rat Model Market Competitive Benchmarking
32. Global Rat Model Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Rat Model Market
34. Rat Model Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
